论文部分内容阅读
Despite the availability of potent chemotherapy regimens,such as 5-fluorouracil,folinic acid,irinotecan,and oxaliplatin(FOLFIRINOX)and nab-paclitaxel plus gemcitabine,treatment outcomes in metastatic pancreatic cancer(PC)remain unsatisfactory.The presence